Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03872518 · ClinicalTrials.gov registry record

A Prospective Case Series Analysis of Initial Users of the Urovac Device

A clinical trial of Incontinence, Urinary, sponsored by Cedars-Sinai Medical Center.

Completed
Registry status
10
Enrollment target
1
Study location

NCT03872518 is a study of Incontinence, Urinary that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 10 participants, below the 177-participant average among 3 other Incontinence, Urinary trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03872518, a study of Incontinence, Urinary, has completed, sponsored by Cedars-Sinai Medical Center.

COMPLETED
Registry status
10 participants
Enrollment target
1
Study location

Study Summary

To document usage of the Urovac device among 30 initial users of the device in an acute rehabilitation facility, with analysis of whether and how patients benefitted, challenges encountered, and how benefits and challenges varied by patient type.

Conditions Studied

Interventions

  • DEVICE Urovac

Study Locations (1)

California

  • California Rehabilitation Institute - Los Angeles

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2019-04-17
Est. Completion 2022-09-30

Sponsor

Cedars-Sinai Medical Center

339 total trials

What the Registry Record Tells You About NCT03872518

The ClinicalTrials.gov registry entry for NCT03872518 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 177-participant average among 3 other Incontinence, Urinary trials with a reported enrollment target (94% lower). The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Incontinence, Urinary appearing as the primary indexed condition, and to 1 intervention - of which Urovac is the first listed.

NCT03872518 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03872518 about?

NCT03872518 is a clinical study titled "A Prospective Case Series Analysis of Initial Users of the Urovac Device". To document usage of the Urovac device among 30 initial users of the device in an acute rehabilitation facility, with analysis of whether and how patients benefitted, challenges encountered, and how benefits and challenges varied by patient type.

What is the current status of trial NCT03872518?

This trial is currently completed. The enrollment target is 10 participants. The study started on 2019-04-17. Estimated completion is 2022-09-30.

What conditions does trial NCT03872518 study?

This clinical trial studies the following conditions: Incontinence, Urinary.

What interventions are being tested in trial NCT03872518?

The interventions under investigation include: Urovac (DEVICE).

Who is sponsoring clinical trial NCT03872518?

This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03872518 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Incontinence, Urinary

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.